滤泡性淋巴瘤单细胞RNA测序揭示恶性B细胞类型及T细胞免疫检查点共表达
该研究对6例原发性滤泡性淋巴瘤(FL)肿瘤的34188个细胞进行单细胞RNA测序,并结合多色流式细胞术验证细胞谱系归属和蛋白表达预测。比较同一患者恶性与正常B细胞基因表达,发现恶性B细胞呈免疫球蛋白轻链限制性表达、BCL2上调及FCER2、CD52和MHC II类基因下调,并鉴定出恶性B细胞亚克隆及与免疫检查点分子共表达的基因(如调节性T细胞中的CEBPA和B2M)。
要点
- 单细胞RNA测序分析6例FL肿瘤共34188个细胞,识别正常免疫亚群和恶性B细胞。
- 恶性B细胞呈限制性Ig轻链表达(Igκ或Igλ)、BCL2上调及FCER2、CD52、MHC II类基因下调。
- 鉴定FL内恶性B细胞亚克隆及调节性T细胞中与免疫检查点共表达的CEBPA和B2M。
核心结论
- 平行测量数千肿瘤细胞和肿瘤浸润淋巴细胞的单细胞表达,可获得肿瘤微环境的系统层面视图,并识别治疗开发的新途径。
研究设计与样本
- 研究对6例原发性FL肿瘤的34188个细胞进行单细胞RNA测序,并用同批肿瘤的多色流式细胞术验证细胞谱系归属和蛋白表达预测。
主要发现
- 与同一患者匹配的正常B细胞相比,恶性B细胞呈限制性Ig轻链表达(Igκ或Igλ)、BCL2基因上调,以及FCER2、CD52和MHC II类基因下调。
- 研究识别了同一FL内共存的恶性B细胞亚克隆,并检查了肿瘤浸润T细胞的特征。
- 在调节性T(Treg)细胞中鉴定出与免疫检查点分子共表达的基因,如CEBPA和B2M。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Follicular lymphoma (FL) is a low-grade B-cell malignancy that transforms into a highly aggressive and lethal disease at a rate of 2% per year. Perfect isolation of the malignant B-cell population from a surgical biopsy is a significant challenge, masking important FL biology, such as immune checkpoint coexpression patterns. To resolve the underlying transcriptional networks of follicular B-cell lymphomas, we analyzed the transcriptomes of 34 188 cells derived from 6 primary FL tumors. For each tumor, we identified normal immune subpopulations and malignant B cells, based on gene expression. We used multicolor flow cytometry analysis of the same tumors to confirm our assignments of cellular lineages and validate our predictions of expressed proteins. Comparison of gene expression between matched malignant and normal B cells from the same patient revealed tumor-specific features. Malignant B cells exhibited restricted immunoglobulin (Ig) light chain expression (either Igκ or Igλ), as well the expected upregulation of the BCL2 gene, but also downregulation of the FCER2, CD52, and major histocompatibility complex class II genes. By analyzing thousands of individual cells per patient tumor, we identified the mosaic of malignant B-cell subclones that coexist within a FL and examined the characteristics of tumor-infiltrating T cells. We identified genes coexpressed with immune checkpoint molecules, such as CEBPA and B2M in regulatory T (Treg) cells, providing a better understanding of the gene networks involved in immune regulation. In summary, parallel measurement of single-cell expression in thousands of tumor cells and tumor-infiltrating lymphocytes can be used to obtain a systems-level view of the tumor microenvironment and identify new avenues for therapeutic development.
引用
- Andor N, Simonds EF, Czerwinski DK, et al. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints. Blood. 2018. PMID: 30591526. doi:10.1182/blood-2018-08-862292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。